, Tracking Stock Market Picks
Enter Symbol:
Complete Genomics, Inc. (GNOM) [hlAlert]

down 77.24 %

Complete Genomics Inc. (GNOM) rated Outperform by William Blair

Posted on: Tuesday,  Apr 19, 2011  11:25 AM ET by William Blair

William Blair rated Outperform Complete Genomics, Inc. (NASDAQ: GNOM) on 04/19/2011, when the stock price was $13.80. Since
then, Complete Genomics, Inc. has lost 77.25% as of 03/18/2015's recent price of $3.14.
If you would have followed this William Blair's recommendation on GNOM, you would have lost 77.24% of your investment in 1429 days.

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. During the year ended December 31, 2010 (during 2010), the Company sequenced over 800 complete human genomes. Its customers include some of the global academic and government research centers and biopharmaceutical companies.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/19/2011 11:25 AM Buy
as of 12/30/2011
1 Week up  2.80 %
1 Month down  -20.81 %
3 Months down  -50.08 %
1 YTD down  -78.76 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy